Concepedia

Gordon M. Cragg

GM

90

Publications

7.5K

Citations

45

H-Index

1966

Active since

Affiliations

National Cancer Institute(Current)

Arizona State University

Frederick National Laboratory for Cancer Research

Drug Discovery Laboratory (Norway)

Gordon M. Cragg is an author at National Cancer Institute specializing in pharmacology, medicine, and drug discovery.

Top concepts

PharmacologyMedicineDrug DiscoveryMedicinal ChemistryNatural SciencesBiochemistryDrug DevelopmentBiologyEngineeringToxicology

Publications per year

1966–2016

90

Publications

90

HIV inhibitory natural products. Part 7. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum

Yoel Kashman, Kirk R. Gustafson, Ray W. Fuller et al. · Journal of Medicinal Chemistry · 1992 · 546 citations

Biodiversity: A continuing source of novel drug leads

Gordon M. Cragg, David Newman · Pure and Applied Chemistry · 2005 · 394 citations · Full text

Engineering, Secondary Metabolite, Fungal Species +20

Natural Product Drug Discovery in the Next Millennium

Gordon M. Cragg, David Newman · Pharmaceutical Biology · 2001 · 374 citations

Bioorganic Chemistry, Medicinal Chemistry, Microbial Ecology +20

Natural Product Drug Discovery and Development: New Perspectives on International Collaboration

Joseph T. Baker, Robert P. Borris, Brad Carté et al. · Journal of Natural Products · 1995 · 346 citations

Engineering, Genetics, New Perspectives +25

The Taxol Supply Crisis. New NCI Policies for Handling the Large-Scale Production of Novel Natural Product Anticancer and Anti-HIV Agents

Gordon M. Cragg, Saul A. Schepartz, Matthew Suffness et al. · Journal of Natural Products · 1993 · 307 citations

Rows per page

1–5 of 90